Sabina A. Murphy

Sabina A. Murphy works in Interventional Cardiology affiliated with Brigham and Women's Hospital.

Sabina A. Murphy serves as the Director of Biostatistics at the TIMI Study Group, which is an academic research organization affiliated with Brigham and Women's Hospital and Harvard Medical School. She contributes to clinical trials focused on cardiovascular diseases, including studies on antiplatelet therapies and outcomes in patients with acute coronary syndromes. Her research involves statistical analysis for trials evaluating treatments like prasugrel, ticagrelor, and evolocumab.